AtriCure, Inc. (ATRC) Posts Q3 EPS Loss of $0.07
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.70 --0%
EPS Growth %: +92.3%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +92.3%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $15.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Commercial Metals (CMC) Tops Q3 EPS by 3c, Beats on Revenue
- Acuity Brands (AYI) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
